TRCT
FMED icon

Tower Research Capital (TRC)’s Fidelity Disruptive Medicine ETF FMED Stock Holding History

Tower Research Capital (TRC)’s Portfolio FMED Stock Details FMED Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q1 		– Sell
-162
Closed -$4K – 5387
2024
Q4 		$4K Hold
162
– – ﹤0.01% 4545
2024
Q3 		$4.26K Hold
162
– – ﹤0.01% 4621
2024
Q2 		$3.9K Hold
162
– – ﹤0.01% 4845
2024
Q1 		$4.13K Hold
162
– – ﹤0.01% 4732
2023
Q4 		$3.92K Buy
162
+50
+45% +$1.08K ﹤0.01% 5026
2023
Q3 		$2.48K Buy
+112
New +$2.68K ﹤0.01% 5143

Other funds holding FMED

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Wealth Enhancement Advisory Services
Wealth Enhancement Advisory Services Plymouth, Minnesota $59.8B AUM 29.42% 1-Year Est. Return
Jane Street
Jane Street New York $777B AUM 61.18% 1-Year Est. Return
PSFG
Park Square Financial Group Roswell, Georgia $11.1M AUM 15.3% 1-Year Est. Return
CPBTD
Central Pacific Bank - Trust Division Honolulu, Hawaii $984M AUM 34.19% 1-Year Est. Return
GEA
Glen Eagle Advisors Kingston, New Jersey $714M AUM 18.87% 1-Year Est. Return

Tower Research Capital (TRC)'s FMED Position: Q1 2025 in Review

Tower Research Capital (TRC) sold out of Fidelity Disruptive Medicine ETF (FMED) in Q1 2025, closing a stake of 162 shares — an estimated $4K sold.

Tower Research Capital (TRC) first reported a position in FMED in Q3 2023 and held it in 6 quarters. The position peaked at $4.26K in Q3 2024. 6 funds tracked by Wall St. Rank hold FMED as of Q1 2025.

  • Tower Research Capital (TRC) reported no remaining Fidelity Disruptive Medicine ETF position as of Q1 2025 after selling out during the quarter.
  • Tower Research Capital (TRC) sold 162 Fidelity Disruptive Medicine ETF shares in Q1 2025, an estimated $4K.
  • Tower Research Capital (TRC) first reported a position in Fidelity Disruptive Medicine ETF in Q3 2023 and held it in 6 quarters.
  • Tower Research Capital (TRC)'s Fidelity Disruptive Medicine ETF position peaked at $4.26K in Q3 2024.
  • 6 funds tracked by Wall St. Rank held Fidelity Disruptive Medicine ETF as of Q1 2025.

Based on Tower Research Capital (TRC)'s 13F filing for Q1 2025, filed 15 May 2025.